Related Experiment Videos

Inflammatory markers in bacterial exacerbations of COPD

Timothy F Murphy, Sanjay Sethi, Susan L Hill

American Journal of Respiratory and Critical Care Medicine

|January 10, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Outcomes of patients with COPD before and after initiation of treatment with budesonide/glycopyrrolate/formoterol fumarate: Results from the US ARCTOS study.

Respiratory medicine·2026

The natural human adaptive IgG-specific immune response is skewed towards non-protective tail domains of DNABII proteins.

Frontiers in immunology·2026

Effect of a self-directed lifestyle-based weight management program among patients with comorbid COPD and sleep apnea: a secondary analysis of the INSIGHT COPD trial.

Annals of the American Thoracic Society·2025

Comparable Clinical Outcomes with Tiotropium/Olodaterol or Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with COPD and Blood Eosinophil Count ≤300 Cells/μL.

International journal of chronic obstructive pulmonary disease·2025

Two randomised controlled phase 2 studies of the oral neutrophil elastase inhibitor alvelestat in alpha-1 antitrypsin deficiency.

The European respiratory journal·2025

Leveraging dynamic stability to infer regulation in protein-protein interaction networks: A study of infectious vulnerability in COPD.

PloS one·2025

See all related articles